Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ATAI |
---|---|---|
09:32 ET | 31282 | 1.45 |
09:34 ET | 16846 | 1.43 |
09:36 ET | 6608 | 1.43 |
09:38 ET | 11314 | 1.43 |
09:39 ET | 14870 | 1.4294 |
09:41 ET | 3967 | 1.4493 |
09:43 ET | 8260 | 1.4575 |
09:45 ET | 6884 | 1.45 |
09:48 ET | 5304 | 1.46 |
09:50 ET | 21990 | 1.47 |
09:52 ET | 1773 | 1.48 |
09:54 ET | 57031 | 1.47 |
09:56 ET | 2050 | 1.47 |
09:57 ET | 2300 | 1.47 |
09:59 ET | 3415 | 1.46 |
10:01 ET | 500 | 1.465 |
10:06 ET | 425 | 1.47 |
10:08 ET | 400 | 1.47 |
10:10 ET | 1500 | 1.465 |
10:12 ET | 900 | 1.465 |
10:14 ET | 1019 | 1.465 |
10:15 ET | 22919 | 1.4799 |
10:17 ET | 3589 | 1.48 |
10:19 ET | 500 | 1.4798 |
10:21 ET | 1900 | 1.48 |
10:24 ET | 1900 | 1.48 |
10:26 ET | 4559 | 1.475 |
10:28 ET | 8730 | 1.48 |
10:30 ET | 100 | 1.48 |
10:32 ET | 2009 | 1.475 |
10:33 ET | 9033 | 1.465 |
10:35 ET | 600 | 1.4699 |
10:37 ET | 100 | 1.4699 |
10:39 ET | 1129 | 1.465 |
10:42 ET | 100 | 1.465 |
10:44 ET | 200 | 1.4687 |
10:46 ET | 14461 | 1.47 |
10:48 ET | 4000 | 1.46 |
10:50 ET | 100 | 1.465 |
10:51 ET | 1000 | 1.46 |
10:53 ET | 5384 | 1.45 |
10:55 ET | 361 | 1.44 |
10:57 ET | 200 | 1.44 |
11:00 ET | 1400 | 1.435 |
11:02 ET | 2500 | 1.43 |
11:04 ET | 100 | 1.435 |
11:06 ET | 2874 | 1.425 |
11:08 ET | 1200 | 1.4234 |
11:09 ET | 510 | 1.4282 |
11:11 ET | 6411 | 1.41 |
11:13 ET | 9299 | 1.41 |
11:15 ET | 3626 | 1.405 |
11:18 ET | 500 | 1.405 |
11:20 ET | 1050 | 1.405 |
11:22 ET | 19126 | 1.4 |
11:24 ET | 7780 | 1.4 |
11:26 ET | 2600 | 1.405 |
11:27 ET | 3638 | 1.405 |
11:29 ET | 4100 | 1.402 |
11:31 ET | 278 | 1.405 |
11:33 ET | 31618 | 1.42 |
11:36 ET | 1835 | 1.42 |
11:38 ET | 2900 | 1.415 |
11:40 ET | 100 | 1.42 |
11:42 ET | 570 | 1.415 |
11:44 ET | 300 | 1.415 |
11:45 ET | 4300 | 1.41 |
11:47 ET | 2550 | 1.4136 |
11:49 ET | 3185 | 1.4099 |
11:51 ET | 200 | 1.405 |
11:56 ET | 100 | 1.405 |
11:58 ET | 3959 | 1.405 |
12:00 ET | 811 | 1.4053 |
12:02 ET | 20966 | 1.41 |
12:03 ET | 6424 | 1.4087 |
12:05 ET | 842 | 1.405 |
12:07 ET | 100 | 1.4 |
12:09 ET | 2450 | 1.405 |
12:12 ET | 1700 | 1.405 |
12:14 ET | 367 | 1.4 |
12:16 ET | 525 | 1.405 |
12:18 ET | 100 | 1.405 |
12:20 ET | 200 | 1.405 |
12:21 ET | 2539 | 1.405 |
12:23 ET | 4755 | 1.415 |
12:25 ET | 1275 | 1.415 |
12:30 ET | 2167 | 1.4168 |
12:32 ET | 477 | 1.4102 |
12:34 ET | 1958 | 1.42 |
12:36 ET | 4264 | 1.415 |
12:38 ET | 800 | 1.415 |
12:39 ET | 200 | 1.415 |
12:41 ET | 2500 | 1.41 |
12:43 ET | 7257 | 1.405 |
12:45 ET | 1345 | 1.4 |
12:48 ET | 4385 | 1.41 |
12:50 ET | 450 | 1.41 |
12:52 ET | 8655 | 1.41 |
12:54 ET | 410 | 1.405 |
12:56 ET | 600 | 1.405 |
12:57 ET | 400 | 1.4 |
12:59 ET | 400 | 1.405 |
01:01 ET | 300 | 1.405 |
01:03 ET | 2400 | 1.4023 |
01:06 ET | 100 | 1.405 |
01:08 ET | 1620 | 1.4 |
01:10 ET | 406 | 1.405 |
01:12 ET | 3100 | 1.405 |
01:14 ET | 1911 | 1.405 |
01:15 ET | 3501 | 1.41 |
01:17 ET | 400 | 1.405 |
01:19 ET | 800 | 1.4028 |
01:21 ET | 550 | 1.4 |
01:24 ET | 100 | 1.4069 |
01:26 ET | 5265 | 1.41 |
01:28 ET | 1600 | 1.41 |
01:30 ET | 6303 | 1.41 |
01:32 ET | 200 | 1.4 |
01:33 ET | 600 | 1.41 |
01:35 ET | 5495 | 1.4 |
01:37 ET | 3778 | 1.4 |
01:39 ET | 16790 | 1.395 |
01:44 ET | 1954 | 1.3901 |
01:46 ET | 1200 | 1.395 |
01:48 ET | 1980 | 1.395 |
01:50 ET | 200 | 1.395 |
01:53 ET | 1100 | 1.39 |
01:55 ET | 500 | 1.3923 |
01:57 ET | 200 | 1.39 |
02:00 ET | 600 | 1.3938 |
02:02 ET | 23435 | 1.4 |
02:04 ET | 2200 | 1.39 |
02:06 ET | 3972 | 1.39 |
02:08 ET | 5200 | 1.39 |
02:09 ET | 3042 | 1.39 |
02:11 ET | 101 | 1.3899 |
02:13 ET | 200 | 1.38 |
02:15 ET | 300 | 1.38 |
02:18 ET | 8646 | 1.385 |
02:20 ET | 800 | 1.3883 |
02:22 ET | 2500 | 1.385 |
02:24 ET | 4581 | 1.38 |
02:26 ET | 100 | 1.385 |
02:27 ET | 1100 | 1.385 |
02:29 ET | 699 | 1.38 |
02:31 ET | 3402 | 1.3848 |
02:33 ET | 1800 | 1.385 |
02:36 ET | 3048 | 1.39 |
02:38 ET | 2108 | 1.38 |
02:40 ET | 1700 | 1.385 |
02:42 ET | 12074 | 1.38 |
02:44 ET | 1380 | 1.3877 |
02:45 ET | 1782 | 1.38 |
02:47 ET | 175 | 1.385 |
02:49 ET | 1000 | 1.38 |
02:51 ET | 900 | 1.385 |
02:54 ET | 2783 | 1.38 |
02:56 ET | 5264 | 1.38 |
02:58 ET | 11624 | 1.385 |
03:00 ET | 1299 | 1.385 |
03:02 ET | 2514 | 1.38 |
03:03 ET | 41340 | 1.365 |
03:05 ET | 20164 | 1.38 |
03:07 ET | 775 | 1.38 |
03:09 ET | 2299 | 1.38 |
03:12 ET | 2775 | 1.3866 |
03:14 ET | 4650 | 1.385 |
03:16 ET | 600 | 1.385 |
03:18 ET | 2323 | 1.39 |
03:20 ET | 3400 | 1.3899 |
03:21 ET | 4800 | 1.385 |
03:23 ET | 7138 | 1.38 |
03:25 ET | 550 | 1.39 |
03:27 ET | 3020 | 1.3899 |
03:30 ET | 7730 | 1.3801 |
03:32 ET | 1900 | 1.38 |
03:34 ET | 3120 | 1.38 |
03:36 ET | 700 | 1.385 |
03:38 ET | 6555 | 1.38 |
03:39 ET | 5560 | 1.385 |
03:41 ET | 2207 | 1.385 |
03:43 ET | 1100 | 1.385 |
03:45 ET | 1563 | 1.38 |
03:48 ET | 3353 | 1.3873 |
03:50 ET | 3632 | 1.38 |
03:52 ET | 3850 | 1.39 |
03:54 ET | 1900 | 1.385 |
03:56 ET | 3434 | 1.38 |
03:57 ET | 11607 | 1.38 |
03:59 ET | 40832 | 1.39 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ATAI Life Sciences NV | 236.0M | -5.8x | --- |
Design Therapeutics Inc | 235.0M | -3.7x | --- |
Candel Therapeutics Inc | 238.9M | -5.5x | --- |
Rezolute Inc | 232.4M | -5.0x | --- |
Omeros Corp | 230.6M | -1.3x | --- |
Opthea Ltd | 229.0M | -1.0x | --- |
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $236.0M |
---|---|
Revenue (TTM) | $277.0K |
Shares Outstanding | 167.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.24 |
Book Value | $1.46 |
P/E Ratio | -5.8x |
Price/Sales (TTM) | 852.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -42,344.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.